There is no vaccine yet. Only claims that what Generex vaccine is composed of and used. It has not proven itself, so why are everyone so caught up about this? If you bought in after the agreement signing between Bintai and Generex, you should also read what the agreement comprises. Buying without research is like throwing money away.
The irony is that ESCERAM is the only glove mould company in Malaysia that supplies gloves to other glove companies. ESCERAM gloves are worth the investment.
So tempting to go in at 72 cts and my friend warned me against making the plunge. Many years ago kena burnt by the dotcom era so very cautious on this company.....
Shark game plan 0.72 - 0.68 buy. Pump up sell 0.74 - 0.78. You buy 0.72 - 0.68 you'd make money. You buy 0.74 - 0.78 you'd lose money. Now left pocket to right pocket trades to unload at 0.75/0.76. That is all there is too it.
Solution Group subsidiary signs agreement with CanSino to distribute novel coronavirus vaccine TheEdge Wed, Sep 23, 2020 03:38pm - 13 minutes ago
KUALA LUMPUR (Sept 23): Solution Group Bhd's subsidiary Solution Biologics Sdn Bhd and China-based CanSino Biologics Inc today signed a registration, manufacturing and commercialisation agreement, which will enable Solution Biologics to market and distribute in Malaysia the novel coronavirus vaccine developed by CanSino.
In a statement to Bursa Malaysia today, Solution Group said Solution Biologics will register with Malaysia's National Pharmaceutical Regulatory Agency to apply for the market authorisation certificate.
Solution Group said Solution Biologics "will establish a state-of-the-art fill and finish facility" to host a technology transfer for the filling, finishing and final quality control of CanSino's recombinant novel coronavirus vaccine.
The facility will be established at Solution Biologics' current premises at PT13796, Jalan Tekno Usahawan 2, Technology Park Malaysia in Bukit Jalil here.
"CanSino will collaborate with Solution Biologics in obtaining the necessary approvals [including the marketing authorisation] for the purposes of the registration and commercialisation of the product in Malaysia.
"Upon the product's registration, CanSino will be partnering with Solution Biologics in supplying to Solution Biologics of bulk product for further manufacturing (fill and finish) of the finished product, its final quality control release and its commercialisation by Solution Biologics in Malaysia," Solution Group said.
"Upon the successful implementation of the terms, interests and the intention of the parties as set out in the agreement, Solution Group expects the collaboration will contribute positively to its earnings in the future," Solution Group said.
At 3.14pm today, Solution Group's share price rose four sen or 5.8% to 73 sen for a market capitalisation of RM223.51 million. The stock saw some 107 million shares traded.
hello friends, wake up. How on earth a effective vaccine given to a second tier company in malaysia to distribute?? also, how a 25 US cents company have the potential to develove or license the vaccine??
Hahaha ... isu politik semalam telah mempengaruhi pasaran Bursa Malaysia .. so kena hati2 juga dengan isu politik ... habis merah semua kaunter semalam ... bagi yg baru belajar trade , perlu ingat isu politik negara juga menyumbang kepada naik turun pasaran Bursa Malaysia ...
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
nanashar
152 posts
Posted by nanashar > 2020-09-23 09:42 | Report Abuse
ddnk said bintai will hit 100% TP 1.33 hihihi